After PDL1-CTLA4 treatment, we found that IGF2BP3 was mainly expressed in HCC cells, while CD8T cells, B cells, hepatocytes and plasma were also a little. This evidence concerns the gene IGF2BP3 and hepatocellular carcinoma.